The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Nagaĭtseva S.S.

Kafedra nefrologii i gemodializa FPPOV Pervogo MGMU im. I.M. Sechenova Minzdrava Rossii

Shalyagin Yu.D.

Moscow Regional Center of Medical Prevention, Moscow, Russia

Shvetsov M.Iu.

Kafedra nefrologii i gemodializa FPPOV Pervogo MGMU im. I.M. Sechenova Minzdrava Rossii

Piagaĭ N.L.

Filial po meditsinskoĭ profilaktike GAUZ Moskovskoĭ oblasti Klinicheskiĭ tsentr vosstanovitel'noĭ meditsiny i reabilitatsii

Shilov E.M.

Kafedra nefrologii

Test strip evaluation of albuminuria for the early detection of chronic kidney disease in persons at different risks (the experience of the Health Centers of the Moscow Region)

Authors:

Nagaĭtseva S.S., Shalyagin Yu.D., Shvetsov M.Iu., Piagaĭ N.L., Shilov E.M.

More about the authors

Journal: Therapeutic Archive. 2013;85(6): 38‑43

Read: 2861 times


To cite this article:

Nagaĭtseva SS, Shalyagin YuD, Shvetsov MIu, Piagaĭ NL, Shilov EM. Test strip evaluation of albuminuria for the early detection of chronic kidney disease in persons at different risks (the experience of the Health Centers of the Moscow Region). Therapeutic Archive. 2013;85(6):38‑43. (In Russ.)

Recommended articles:
Chro­nic inflammation in case of obesity-associated diseases. Russian Journal of Preventive Medi­cine. 2025;(1):115-121
Identification of prognostic significant markers of early diagnosis of obesity and meta­bolic diso­rders. Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(6-2):71-79
Psoriasis: analysis of como­rbid pathology. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(1):16-21

References:

  1. Smirnov A.V., Dobronravov V.A., Kayukov I.G. i dr. Epidemiologiya i sotsial'no-ekonomicheskie aspekty khronicheskoi bolezni pochek. Nefrologiya 2006; 1: 7-13.
  2. Bikbov B.T., Tomilina N.A. Sostoyanie zamestitel'noi terapii bol'nykh s khronicheskoi pochechnoi nedostatochnost'yu v Rossiiskoi Federatsii v 1998-2007 gg. (Analiticheskii otchet po dannym Rossiiskogo registra zamestitel'noi pochechnoi terapii). Nefrol i dializ 2009; 3: 144-233.
  3. Xue J.L., Ma J.Z., Louis T.A., Collins A.J. Forecast of the number of patients with end-stage renal disease in the United States to the year 2010. J Am Soc Nephrol 2001; 12: 2753-2758.
  4. Dobronravov V.A., Smirnov A.V., Dragunov S.V. i dr. Epidemiologiya khronicheskoi bolezni pochek v Vologodskoi oblasti. Nefrologiya 2004; 1: 36-41.
  5. Shvetsov M.Yu., Bobkova I.N., Kolina I.B., Kamyshova E.S. Sovremennye printsipy diagnostiki i lecheniya khronicheskoi bolezni pochek: metodicheskoe rukovodstvo dlya vrachei. Pod red. E.M. Shilova. Saratov 2011.
  6. Smirnov A.V., Dobronravov V.A., Kayukov I.G. i dr. Rekomendatsii Nauchno-issledovatel'skogo instituta nefrologii Sankt-Peterburgskogo gosudarstvennogo meditsinskogo universiteta im. akad. I.P. Pavlova: opredelenie, klassifikatsiya, diagnostika i osnovnye napravleniya profilaktiki khronicheskoi bolezni pochek u vzroslykh. Nefrologiya 2008; 2: 75-93.
  7. Vassalotti J.A., Stevens L.A., Levey A.S. Testing for chronic kidney disease: a position statement from the National Kidney Foundation. Am J Kidney Dis 2007; 50 (2): 169-180.
  8. De Jong P.E., Verhave J.C, Pinto-Siestma S.J. et al. Obesity and target organ damage: the kidney. Int J Obes Relat Metab Disord 2002; 26 (Supp l4): S21-S24.
  9. Zavie C.J., Milani R.V. Obesity and cardiovascular disease: the Hyppocrates paradox? J Am Coll Cardiol 2003; 42: 677-679.
  10. Schaeffher E.S., Kurth T., Curhan G.C. et al. Cholesterol and the risk of renal dysfunction in apparently healthy men. J Am Soc Nephrol 2003; 14: 2084-2091.
  11. Stuveling E.M., Bakker S.J., Hilige H.X. et al. Biochemical risk markers: a novel area for better prediction of renal risk? Nephrol Dial Transplant 2005; 20: 497-508.
  12. Mukhin N.A., Moiseev V.S., Kobalava Zh.D. i dr. Kardiorenal'nye vzaimodeistviya: klinicheskoe znachenie i rol' v patogeneze zabolevanii serdechno-sosudistoi sistemy i pochek. Ter arkh 2004; 6: 39-46.
  13. Verhave J.C, Hillege H.Z., Burgerhof G.M. et al. The association between atherosclerotic risk factors and renal function in the general population. Kidney Int 2005; 67: 1967-1973.
  14. Schiepati A., Remuzzi G. Chronic renal disease as a public health problem: Epidemiology, social and economic implications. Kidney Int 2005; 68 (Suppl. 98): S7-S10.
  15. Pinto-Siersma S.J., Mulder J., Janssen W.M. et al. Smoking is related to albuminuria and abnormal renal function in nondiabetic persons. Ann Intern Med 2000; 133: 585-591.
  16. Warmoth L., Regalado M.M., Simoni J. et al. Cigarette smoking enhances increased urine albumin excretion as a risk factor for glomerular filtration rate decline in primary hypertension. Am J Med Sci 2005; 330 (3): 111-119.
  17. Orth S.R. Smoking and the kidney. J Am Soc Nephrol 2002; 13: 1663-1672.
  18. Haroun N.K., Jaar B.G., Hoffman S.C. et al. Risk factors for chronic Kidney disease: a prospective study of 23.534 men and women in Washington Country, Maryland. J Am Soc Nephrol 2003; 14: 2934-2941.
  19. Atkins R.C. The epidemiology of chronic kidney disease. Kidney Int 2005; 67 (Suppl. 94): S14-S18.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.